Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components
about
Repression by a differentiation-specific factor of the human cytomegalovirus enhancerFlip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.Improved conditional expression systems resulting in physiological level of HNF4alpha expression confirm HNF4alpha induced apoptosis in the pancreatic beta-cell line INS-1.Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicityPersistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins.Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latencyA shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia.BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro.A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome.Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoterFunctional properties of the human cytomegalovirus IE86 protein required for transcriptional regulation and virus replicationA transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus.Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication.Insertion and deletion mutagenesis of the human cytomegalovirus genomeFunctional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx.Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer.Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceCytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription.Hepatocyte-stimulating factor, beta 2 interferon, and interleukin-1 enhance expression of the rat alpha 1-acid glycoprotein gene via a distal upstream regulatory regionThe variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formationMultiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infectionCellular or viral protein binding to a cytomegalovirus promoter transcription initiation site: effects on transcription.Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirusExpression from herpesvirus promoters does not relieve the intron requirement for cytoplasmic accumulation of human beta-globin mRNA.Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter.Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.The status of CMV as a human pathogen.The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin.TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinIdentification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complexMutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.
P2860
Q24316464-9770E89A-FDA1-49ED-A557-ACD54C8F6606Q30826113-0B860229-F0E9-451A-9C30-9B6E5926E967Q33511037-EA3498AC-062A-45F8-9D25-7015E2E4E120Q33639601-766DE433-00F3-47D8-90B8-249B9E3ECAF7Q33783411-23EB0057-3D5A-4C49-B2F0-E1E35C5F34A4Q33785172-B1010F7A-FFF2-4A11-8313-7630AC89F269Q33797024-35792D41-1370-44D7-BA20-131B73C65040Q33841123-AEB82AE2-EC85-423A-83DF-688BB85BBCEAQ33864423-BC8F116E-6A30-40EC-9AD4-5996A46D3DA6Q33930251-68192391-118F-47F0-A193-124185898F96Q33936221-03D6AAF1-8DE7-4948-BB50-3955F8CEE998Q33937888-9E8805E0-37B9-4ECB-A25F-FEC9C297D4A9Q34045753-B2E2A463-9509-4795-A6C5-707B425B0801Q34055426-2E46A962-3DC6-45B2-AE5A-C6BC52681EB6Q34061465-AC17A5B9-C56E-48CE-9013-5F85DE6E7F82Q34288246-4C1847A9-2489-4165-A9CD-C3FF96FED88CQ34326898-FE186B95-1676-4A77-A526-175AF806686FQ34354191-F68FD935-F190-4782-A94F-8510122A7DF1Q34365016-BD40EC08-FE5C-4195-AEBF-4D9F82B0C970Q34626976-E79DF7B0-5FEB-4E42-81F8-C4F5AF048627Q35020175-00721FEC-F1C9-4BAF-AC32-A94C64412C50Q35076638-506A75C0-EC6A-44AC-B0A4-FCC614045197Q35609621-2249700E-5BB3-436C-87E8-AE2820950133Q35619135-A8724588-1910-4041-8A5F-B50E6C3A927FQ35793329-A90C106F-7E66-44AE-86AD-E0F771868537Q35796608-39F3D984-C0B4-4E47-9124-318CC739C71FQ35853699-DE049F86-8DC9-4B07-B136-FAE56F577526Q35861289-5426DFBB-61EC-46A8-ABD4-6365B6666ADFQ35866154-4EAC1539-6641-42E2-8B2A-1DA3F4F86FB1Q35887805-C0ABF086-B16B-41E5-8BED-B9CAACD8EFDDQ36000905-5635DC79-5010-40DB-A927-0C3D394E1BA1Q36069170-64138457-7E40-4B9F-86B1-53CFD3631FEBQ36090467-D61D874C-50C8-48A2-BDCE-BB0EB824A6EEQ36472493-F11BFA3E-E0AD-42F3-9DE4-C7FA8C84CF7FQ36626536-A1B12088-655D-409A-B7B6-202057F6486AQ36639281-05C0F40B-679F-47F6-B1E5-4513C148D24EQ36640150-6951674D-C437-4B88-AA6A-78B996EC274EQ36644940-65131EE4-5D31-46E5-A380-4EDACBEC44FCQ36646716-1D50D032-846E-4291-9BDE-3124EB1FE492Q36655549-B2754B6F-5F4A-4478-A330-86F348374C98
P2860
Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Activation of the major immedi ...... ecific trans-acting components
@en
type
label
Activation of the major immedi ...... ecific trans-acting components
@en
prefLabel
Activation of the major immedi ...... ecific trans-acting components
@en
P2860
P1433
P1476
Activation of the major immedi ...... ecific trans-acting components
@en
P2093
M F Stinski
P2860
P304
P407
P577
1985-08-01T00:00:00Z